In theory, yes, but delivery of the CRISPR enzyme to all the infected nuclei is still an unsolved problem. Also, it doesn't cut its target every time it does get in - some of the protein is inactive (probably just broken/malformed/misfolded) - but increasing the dose to compensate leads to more instances where it cuts the wrong target.